Leading companies and institutes in protein diagnostics and micro-nano-bio research, including Philips, imec, Hytest, PolyAn, Bremen University and Eindhoven University of Technology, have joined forces to investigate next generation technologies with the goal of enabling new highly sensitive blood tests for instant diagnostics near the patient.
This could help to provide care-givers with relevant information for making on-the-spot decisions in a single patient interaction, with the possibility of streamlining healthcare processes and enabling new care models. Read the full NextDX press release

Funded by the European Union